MétaCan
Menu
Back to cohort
Record W2138543778 · doi:10.1093/hmg/ddr227

Ataxin-2 repeat-length variation and neurodegeneration

2011· article· en· W2138543778 on OpenAlexafffund
Owen A. Ross, Nicola J. Rutherford, Matthew Baker, Alexandra I. Soto‐Ortolaza, Minerva M. Carrasquillo, M. DeJesus-Hernandez, Joy Adamson, M. Li, Kathryn Volkening, Elizabeth Finger, William W. Seeley, Kimmo J. Hatanpaa, Catherine Lomen‐Hoerth, Andrew Kertesz, Eileen H. Bigio, Carol F. Lippa, Bryan K. Woodruff, David S. Knopman, Charles L. White, Jay A. van Gerpen, James F. Meschia, Ian R. Mackenzie, Khrista Boylan, Bradley F. Boeve, Bruce L. Miller, Michael J. Strong, Ryan J. Uitti, Steven G. Younkin, N. R. Graff-Radford, Ronald Petersen, Zbigniew K. Wszołek, Dennis W. Dickson, Rosa Rademakers

Bibliographic record

VenueHuman Molecular Genetics · 2011
Typearticle
Languageen
FieldNeuroscience
TopicGenetic Neurodegenerative Diseases
Canadian institutionsUniversity of British ColumbiaWestern University
FundersNational Institute of Neurological Disorders and StrokeCanadian Institutes of Health ResearchNational Institute on AgingNational Institutes of HealthALS Association
KeywordsAmyotrophic lateral sclerosisBiologySpinocerebellar ataxiaFrontotemporal lobar degenerationTrinucleotide repeat expansionGeneticsDiseaseNeurodegenerationAlleleProgressive supranuclear palsyDegenerative diseaseFrontotemporal dementiaPhenotypeInternal medicineCentral nervous system diseaseDementiaMedicineAtrophyGeneNeuroscience

Abstract

fetched live from OpenAlex

Expanded glutamine repeats of the ataxin-2 (ATXN2) protein cause spinocerebellar ataxia type 2 (SCA2), a rare neurodegenerative disorder. More recent studies have suggested that expanded ATXN2 repeats are a genetic risk factor for amyotrophic lateral sclerosis (ALS) via an RNA-dependent interaction with TDP-43. Given the phenotypic diversity observed in SCA2 patients, we set out to determine the polymorphic nature of the ATXN2 repeat length across a spectrum of neurodegenerative disorders. In this study, we genotyped the ATXN2 repeat in 3919 neurodegenerative disease patients and 4877 healthy controls and performed logistic regression analysis to determine the association of repeat length with the risk of disease. We confirmed the presence of a significantly higher number of expanded ATXN2 repeat carriers in ALS patients compared with healthy controls (OR = 5.57; P= 0.001; repeat length >30 units). Furthermore, we observed significant association of expanded ATXN2 repeats with the development of progressive supranuclear palsy (OR = 5.83; P= 0.004; repeat length >30 units). Although expanded repeat carriers were also identified in frontotemporal lobar degeneration, Alzheimer's and Parkinson's disease patients, these were not significantly more frequent than in controls. Of note, our study identified a number of healthy control individuals who harbor expanded repeat alleles (31-33 units), which suggests caution should be taken when attributing specific disease phenotypes to these repeat lengths. In conclusion, our findings confirm the role of ATXN2 as an important risk factor for ALS and support the hypothesis that expanded ATXN2 repeats may predispose to other neurodegenerative diseases, including progressive supranuclear palsy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.103
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.058
GPT teacher head0.259
Teacher spread0.201 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations172
Published2011
Admission routes2
Has abstractyes

Explore more

Same venueHuman Molecular GeneticsSame topicGenetic Neurodegenerative DiseasesFrench-language works237,207